Testing effectiveness (Phase 2)Ended earlyNCT00069992
What this trial is testing
Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML
Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes
Baylor College of Medicine 7